15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Si-Bone Inc, 6 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $18.00 to $27.00, a moderate spread. The average target of $23.50 sits 31% above the current $17.91. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.13 next quarter toward $-0.35 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Moderate Buy
Strong Buy00%
Buy6100%
Hold00%
Sell00%
Strong Sell00%
Based on 6 analysts giving stock ratings to Si-Bone Inc.
As of Jul, 6 of 6 firms rate SIBN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
SIBN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.13
Range $-0.16 – $-0.10 · 7 analysts · +18% YoY
Next period, 7 analysts expect Si-Bone Inc to earn $-0.13 a share (range $-0.16 – $-0.10), versus $-0.11 a year earlier. Full-year consensus is $-0.43, growing to $-0.35 the year after.
REVENUE · NEXT QUARTER
$55.7M
Range $55.2M – $56.3M · 7 analysts · +15% YoY
Revenue is expected to reach $55.7M (range $55.2M – $56.3M), +14.5% year-over-year. Full-year consensus is $231.6M, rising to $266.6M next year.
Top analysts covering Si-Bone Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SIBN.
#1
Ross Osborn
Cantor Fitzgerald · Rank #139
Buy
$25.00+39.6% to target
Overall win rate
34%
+ Follow
#2
David Saxon
Needham · Rank #264
Buy
$27.00+50.8% to target
Overall win rate
34%
+ Follow
#3
David Turkaly
JMP Securities · Rank #276
Buy
$32.00+78.7% to target
Overall win rate
31%
+ Follow
#4
SB
Samuel Brodovsky
Truist Securities
Buy
$20.00+11.7% to target
Coverage
—
+ Follow
#5
Richard Newitter
Truist Securities
Buy
$21.00+17.3% to target
Coverage
—
+ Follow
SIBN stock forecast FAQ
What is SIBN's average 12-month price target?+
The 6 analysts with a live target average $23.50 for Si-Bone Inc over the next 12 months, ranging from a $27.00 high to a $18.00 low.
Is SIBN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 6 analyst ratings, 6 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for SIBN?+
The Street-high target is $27.00 (Canaccord Genuity), and the Street-low is $18.00 (TD Cowen). The average of all 6 active targets is $23.50.
How many Wall Street analysts cover SIBN?+
6 analysts have an active rating on Si-Bone Inc, and 6 firms carry a live 12-month price target.
Who is the most accurate analyst covering SIBN?+
Among analysts who currently cover SIBN, Ross Osborn of Cantor Fitzgerald has the strongest overall Quantellect track record (Rank #139). Their current call is Buy with a $25.00 target.
What is Si-Bone Inc's projected EPS for next quarter?+
The consensus estimate is $-0.13 per share (range $-0.16 – $-0.10) across 7 analysts. Full-year EPS is projected at $-0.43, rising to $-0.35 the following year.
How much revenue is Si-Bone Inc expected to report next quarter?+
Consensus revenue is $55.7M (range $55.2M – $56.3M). Full-year revenue is projected at $231.6M, growing to $266.6M next year.
Have analysts been upgrading or downgrading SIBN lately?+
As of Jul, 6 of 6 firms rate SIBN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SIBN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
